Article info

Download PDFPDF

Original research
Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study

Authors

  1. Correspondence to Dr Reema Mody; mody_reema{at}lilly.com
View Full Text

Citation

Mody R, Huang Q, Yu M, et al
Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study

Publication history

  • Received September 13, 2019
  • Accepted October 1, 2019
  • First published December 9, 2019.
Online issue publication 
May 15, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.